Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Cancer Letters|November 4, 2018
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1Masashi Namba, Noboru Hattori, Hironobu Hamada, et al.Free Radical Biology & Medicine|April 2, 2019
Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stressYusuke Izumi, Taku Nakashima, Takeshi Masuda, et al.Medicine|January 9, 2020
Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reportsShun Takao, Takeshi Masuda, Takahiro Yamada, et al.Journal of Cellular and Molecular Medicine|February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblastsTakeshi Masuda, Taku Nakashima, Masashi Namba, et al.Respiratory Research|June 13, 2020
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosisKakuhiro Yamaguchi, Hiroshi Iwamoto, Witold Mazur, et al.Stem Cell Research & Therapy|September 17, 2021
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosisShun Takao, Taku Nakashima, Takeshi Masuda, et al.Cancers|February 25, 2023
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal TransitionKentaro Tokumo, Takeshi Masuda, Taku Nakashima, et al.Molecular Cancer Therapeutics|November 6, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung CancerMasahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji, et al.Journal of Translational Medicine|November 28, 2023
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progressionKiyofumi Shimoji, Taku Nakashima, Takeshi Masuda, et al.Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinomaKentaro Tokumo, Takeshi Masuda, Takahiko Miyama, et al.Pageof 12